Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Characterization of the immune response induced by a commercially available inactivated bluetongue virus serotype 1 vaccine in sheep.

Pérez de Diego AC, Sánchez-Cordón PJ, de las Heras AI, Sánchez-Vizcaíno JM.

ScientificWorldJournal. 2012;2012:147158. doi: 10.1100/2012/147158. Epub 2012 Apr 24.

2.

Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8.

van Gennip RG, van de Water SG, Maris-Veldhuis M, van Rijn PA.

PLoS One. 2012;7(9):e44619. doi: 10.1371/journal.pone.0044619. Epub 2012 Sep 25.

3.

Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.

Eschbaumer M, Hoffmann B, König P, Teifke JP, Gethmann JM, Conraths FJ, Probst C, Mettenleiter TC, Beer M.

Vaccine. 2009 Jun 24;27(31):4169-75. doi: 10.1016/j.vaccine.2009.04.056. Epub 2009 May 9.

PMID:
19406189
4.

Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.

Hamers C, Rehbein S, Hudelet P, Blanchet M, Lapostolle B, Cariou C, Duboeuf M, Goutebroze S.

Vaccine. 2009 May 11;27(21):2789-93. doi: 10.1016/j.vaccine.2009.02.099. Epub 2009 Mar 10.

PMID:
19366576
5.

Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.

Bartram DJ, Heasman L, Batten CA, Oura CA, Plana-Durán J, Yuen HM, Wylie AD.

Vet J. 2011 May;188(2):193-6. doi: 10.1016/j.tvjl.2010.04.001. Epub 2010 May 13.

PMID:
20466568
6.

Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.

Oura CA, Wood JL, Sanders AJ, Bin-Tarif A, Henstock M, Edwards L, Floyd T, Simmons H, Batten CA.

Vaccine. 2009 Dec 9;27(52):7326-30. doi: 10.1016/j.vaccine.2009.09.070. Epub 2009 Sep 26.

PMID:
19786141
7.

Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine.

Oura CA, Wood JL, Floyd T, Sanders AJ, Bin-Tarif A, Henstock M, Edwards L, Simmons H, Batten CA.

Vaccine. 2010 Mar 24;28(15):2749-53. doi: 10.1016/j.vaccine.2010.01.028. Epub 2010 Jan 30.

PMID:
20123052
8.

Vaccines against bluetongue in Europe.

Savini G, MacLachlan NJ, Sanchez-Vizcaino JM, Zientara S.

Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):101-20. Epub 2007 Aug 31.

PMID:
17765305
9.

An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.

Savini G, Ronchi GF, Leone A, Ciarelli A, Migliaccio P, Franchi P, Mercante MT, Pini A.

Vet Microbiol. 2007 Sep 20;124(1-2):140-6. Epub 2007 Apr 8.

PMID:
17499459
10.

Studies on the safety and immunogenicity of the South African bluetongue virus serotype 2 monovalent vaccine: specific detection of the vaccine strain genome by RT-PCR.

Hammoumi S, Breard E, Sailleau C, Russo P, Grillet C, Cetre-Sossah C, Albina E, Sanchis R, Pepin M, Guibert JM, Zientara S.

J Vet Med B Infect Dis Vet Public Health. 2003 Sep;50(7):316-21.

PMID:
14535928
11.

Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.

Bréard E, Belbis G, Hamers C, Moulin V, Lilin T, Moreau F, Millemann Y, Montange C, Sailleau C, Durand B, Desprat A, Viarouge C, Hoffmann B, de Smit H, Goutebroze S, Hudelet P, Zientara S.

Vaccine. 2011 Mar 16;29(13):2495-502. doi: 10.1016/j.vaccine.2010.12.105. Epub 2011 Jan 21.

PMID:
21256877
12.

Immunologic response of sheep to inactivated and virulent bluetongue virus.

Stott JL, Barber TL, Osburn BI.

Am J Vet Res. 1985 May;46(5):1043-9.

PMID:
2988376
13.

Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep.

Umeshappa CS, Singh KP, Pandey AB, Singh RP, Nanjundappa RH.

Vaccine. 2010 Mar 16;28(13):2522-31. doi: 10.1016/j.vaccine.2010.01.039. Epub 2010 Jan 29.

PMID:
20117268
14.

Potency and efficacy of inactivated bluetongue virus vaccines.

Stevens DR, Stott J, Osburn BI, Giles R, Wiesehahn GP, Barber TL.

Prog Clin Biol Res. 1985;178:649-52.

PMID:
2989914
15.

Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.

Martelli P, Cordioli P, Alborali LG, Gozio S, De Angelis E, Ferrari L, Lombardi G, Borghetti P.

Vaccine. 2007 Apr 30;25(17):3400-8. Epub 2007 Jan 5.

PMID:
17276558
16.

Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.

Stewart M, Dovas CI, Chatzinasiou E, Athmaram TN, Papanastassopoulou M, Papadopoulos O, Roy P.

Vaccine. 2012 Mar 9;30(12):2131-9. doi: 10.1016/j.vaccine.2012.01.042. Epub 2012 Jan 26.

PMID:
22285887
17.

Laboratory evaluation of a living attenuated vaccine against bluetongue type 20 virus.

Wark MC, Shepherd-Clark MB, Smith HV, Collins WD.

Aust Vet J. 1982 Jul;59(1):6-10.

PMID:
6293439
19.

Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.

Savini G, Hamers C, Conte A, Migliaccio P, Bonfini B, Teodori L, Di Ventura M, Hudelet P, Schumacher C, Caporale V.

Vet Microbiol. 2009 Jan 1;133(1-2):1-8. doi: 10.1016/j.vetmic.2008.05.032. Epub 2008 Jun 8.

PMID:
18617335
20.

Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle.

Wäckerlin R, Eschbaumer M, König P, Hoffmann B, Beer M.

Vaccine. 2010 Jun 17;28(27):4348-55. doi: 10.1016/j.vaccine.2010.04.055. Epub 2010 May 14.

PMID:
20438878
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk